By
Drug Target Review2024-02-07T12:00:50
Researchers found that resolvinT4 restores protective macrophage biological activities in rheumatoid arthritis patients.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-15T13:47:00Z
2026-05-11T12:59:00Z
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-04-04T15:03:09
Sponsored by Agilent
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud